Home > News > Analyzing nanoparticle levels in blood
May 22nd, 2007
Analyzing nanoparticle levels in blood
Abstract:
With the race to develop nanoparticle-based therapeutics and imaging agents for cancer applications moving at full speed, a small but growing group of researchers is quietly developing the methods that are needed to fully characterize a wide variety of nanoscale materials and then detect and quantify their presence in blood and other human tissues. One such effort, headed by King Chan, Ph.D., of the National Cancer Institute, and Anil Patri, Ph.D., of the Nanotechnology Characterization Laboratory, has now developed a straightforward method for analyzing two types of fullerene nanoparticle.
Source:
nanowerk.com
Related News Press |
Nanomedicine
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Leading the charge to better batteries February 28th, 2025
Quantum interference in molecule-surface collisions February 28th, 2025
New ocelot chip makes strides in quantum computing: Based on "cat qubits," the technology provides a new way to reduce quantum errors February 28th, 2025
Safety-Nanoparticles/Risk management
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Tests find no free-standing nanotubes released from tire tread wear September 8th, 2023
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |